|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/12 | |||
| A61K 39/295 | |||
| C07K 14/015 | |||
| C07K 14/045 |
| (11) | Patento numeris | 2729165 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12735420.7 |
| Europos patento paraiškos padavimo data | 2012-07-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-05-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/045847 |
| Data | 2012-07-06 |
| (87) | Numeris | WO 2013/006838 |
| Data | 2013-01-10 |
| (30) | Numeris | Data | Šalis |
| 201161505093 P | 2011-07-06 | US |
| (72) |
GEALL, Andrew, US
SETTEMBRE, Ethan, US
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF |
| IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF |